Copyright
©The Author(s) 2020.
World J Stem Cells. Nov 26, 2020; 12(11): 1237-1254
Published online Nov 26, 2020. doi: 10.4252/wjsc.v12.i11.1237
Published online Nov 26, 2020. doi: 10.4252/wjsc.v12.i11.1237
Breast cancer | Target/Pathway | Treatment Phase | Drug name | Ref. |
BC | CXCR4 | - | Plerixafor | [136] |
BC | TGFß | - | Trabedersen | [137] |
BC | DDL4/Notch | I | Demcizumab | [138] |
BC, TNBC | Notch3 | I | AntiNotch3-ADC | [139] |
BC | Wnt | I | Ipafricept | [140] |
BC | PI3K | I | Alpelisib | [141] |
TNBC | PI3K | I | Buparlisib | [142] |
MBC | CXCR1 | Ib | Reparixin | [143] |
BC | EpCAM | II | Adecatumumab | [144] |
TNBC | Notch | II | Nirogacestat | [145] |
MTNBC | JAK | II | Ruxolitinib | [146] |
MBC | VEGF | III | Bevacizumab | [147] |
- Citation: Mendoza-Almanza G, Burciaga-Hernández L, Maldonado V, Melendez-Zajgla J, Olmos J. Role of platelets and breast cancer stem cells in metastasis. World J Stem Cells 2020; 12(11): 1237-1254
- URL: https://www.wjgnet.com/1948-0210/full/v12/i11/1237.htm
- DOI: https://dx.doi.org/10.4252/wjsc.v12.i11.1237